Your browser doesn't support javascript.
loading
Post-progression outcomes of NSCLC patients with PD-L1 expression ≥ 50% receiving first-line single-agent pembrolizumab in a large multicentre real-world study.
Cortellini, Alessio; Cannita, Katia; Tiseo, Marcello; Cortinovis, Diego L; Aerts, Joachim G J V; Baldessari, Cinzia; Giusti, Raffaele; Ferrara, Miriam G; D'Argento, Ettore; Grossi, Francesco; Guida, Annalisa; Berardi, Rossana; Morabito, Alessandro; Genova, Carlo; Antonuzzo, Lorenzo; Mazzoni, Francesca; De Toma, Alessandro; Signorelli, Diego; Gelibter, Alain; Targato, Giada; Rastelli, Francesca; Chiari, Rita; Rocco, Danilo; Gori, Stefania; De Tursi, Michele; Mansueto, Giovanni; Zoratto, Federica; Filetti, Marco; Bracarda, Sergio; Citarella, Fabrizio; Russano, Marco; Cantini, Luca; Nigro, Olga; Buti, Sebastiano; Minuti, Gabriele; Landi, Lorenza; Ricciardi, Serena; Migliorino, Maria R; Natalizio, Salvatore; Simona, Carnio; De Filippis, Marco; Metro, Giulio; Adamo, Vincenzo; Russo, Alessandro; Spinelli, Gian P; Di Maio, Massimo; Banna, Giuseppe L; Friedlaender, Alex; Addeo, Alfredo; Pinato, David J.
Afiliação
  • Cortellini A; Department of Biotechnology and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy; Division of Cancer, Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital, London, UK. Electronic address: a.cortellini@imperial.ac.uk.
  • Cannita K; Medical Oncology, St. Salvatore Hospital, L'Aquila, Italy.
  • Tiseo M; Department of Medicine and Surgery, University of Parma, Parma, Italy; Medical Oncology Unit, University Hospital of Parma, Parma, Italy.
  • Cortinovis DL; Medical Oncology, Ospedale San Gerardo, Monza, Italy.
  • Aerts JGJV; Department of Pulmonary Diseases, Erasmus Medical Center, Rotterdam, the Netherlands.
  • Baldessari C; Dipartimeto di Oncologia Ed Ematologia, AOU Policlinico Modena, Modena, Italy.
  • Giusti R; Medical Oncolgy, St. Andrea Hospital, Rome, Italy.
  • Ferrara MG; Comprehensive Cancer Center, Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Rome, Italy; Department of Translational Medicine and Surgery, Università Cattolica Del Sacro Cuore, Romae, Lazio, Italy.
  • D'Argento E; Comprehensive Cancer Center, Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Rome, Italy.
  • Grossi F; Medical Oncology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Guida A; Department of Oncology, Azienda Ospedaliera Santa Maria, Terni, Italy.
  • Berardi R; Oncology Clinic, Università Politecnica Delle Marche, Ospedali Riuniti Di Ancona, Ancona, Italy.
  • Morabito A; Thoracic Medical Oncology, Istituto Nazionale Tumori 'Fondazione G Pascale', IRCCS, Napoli, Italy.
  • Genova C; Lung Cancer Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
  • Antonuzzo L; Department of Oncology, Careggi University Hospital, Florence, Italy.
  • Mazzoni F; Department of Oncology, Careggi University Hospital, Florence, Italy.
  • De Toma A; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.
  • Signorelli D; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy.
  • Gelibter A; Medical Oncology (B), Policlinico Umberto I, "Sapienza" University of Rome, Rome, Italy.
  • Targato G; Department of Oncology, University Hospital Santa Maria Della Misericordia, Udine, Italy.
  • Rastelli F; Medical Oncology, Fermo Area Vasta 4, Fermo, Italy.
  • Chiari R; Medical Oncology, Ospedali Riuniti Padova Sud "Madre Teresa Di Calcutta", Monselice, Italy.
  • Rocco D; Pneumo-Oncology Unit, Monaldi Hospital, Naples, Italy.
  • Gori S; Oncology Unit, IRCCS Ospedale Sacro Cuore Don Calabria, Negrar, VR, Italy.
  • De Tursi M; Department of Medical, Oral & Biotechnological Sciences University G. D'Annunzio, Chieti-Pescara, Chieti, Italy.
  • Mansueto G; Medical Oncology, F. Spaziani Hospital, Frosinone, Italy.
  • Zoratto F; Medical Oncology, Santa Maria Goretti Hospital, Latina, Italy.
  • Filetti M; Medical Oncolgy, St. Andrea Hospital, Rome, Italy.
  • Bracarda S; Struttura Complessa di Oncologia Medica e Traslazionale, Azienda Ospedaliera Santa Maria di Terni, Italy.
  • Citarella F; Medical Oncology, Campus Bio-Medico University, Rome, Italy.
  • Russano M; Medical Oncology, Campus Bio-Medico University, Rome, Italy.
  • Cantini L; Department of Pulmonary Diseases, Erasmus Medical Center, Rotterdam, the Netherlands; Oncology Clinic, Università Politecnica Delle Marche, Ospedali Riuniti Di Ancona, Ancona, Italy.
  • Nigro O; Medical Oncology, ASST-Sette Laghi, Varese, Italy.
  • Buti S; Medical Oncology Unit, University Hospital of Parma, Parma, Italy.
  • Minuti G; Department of Oncology and Hematology, AUSL Romagna, Ravenna, Italy.
  • Landi L; Department of Oncology and Hematology, AUSL Romagna, Ravenna, Italy.
  • Ricciardi S; Pneumo-Oncology Unit, St. Camillo-Forlanini Hospital, Rome, Italy.
  • Migliorino MR; Pneumo-Oncology Unit, St. Camillo-Forlanini Hospital, Rome, Italy.
  • Natalizio S; Dipartimento di Oncologia Ed Ematologia, Università Modena e Raggio Emilia, Modena, Italy.
  • Simona C; Department of Oncology, University of Turin, San Luigi Hospital, Orbassano, TO, Italy.
  • De Filippis M; Department of Oncology, University of Turin, San Luigi Hospital, Orbassano, TO, Italy.
  • Metro G; Department of Medical Oncology, Santa Maria Della Misericordia Hospital, Azienda Ospedaliera di Perugia, Perugia, Italy.
  • Adamo V; Medical Oncology, A.O. Papardo & Department of Human Pathology, University of Messina, Italy.
  • Russo A; Medical Oncology, A.O. Papardo & Department of Human Pathology, University of Messina, Italy.
  • Spinelli GP; UOC Territorial Oncology of Aprilia, AUSL Latina, University of Rome Sapienza, Aprilia, Italy.
  • Di Maio M; Department of Oncology, University of Turin and Medical Oncology, AO Ordine Mauriziano, Turin, Italy.
  • Banna GL; Portsmouth Hospitals University NHS Trust, Portsmouth, UK.
  • Friedlaender A; Oncology Department, University Hospital of Geneva, Geneva, Switzerland.
  • Addeo A; Oncology Department, University Hospital of Geneva, Geneva, Switzerland.
  • Pinato DJ; Division of Cancer, Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital, London, UK; Department of Translational Medicine, Università Del Piemonte Orientale "A. Avogadro", Novara, Italy.
Eur J Cancer ; 148: 24-35, 2021 05.
Article em En | MEDLINE | ID: mdl-33721704
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ósseas / Carcinoma Pulmonar de Células não Pequenas / Anticorpos Monoclonais Humanizados / Antígeno B7-H1 / Antineoplásicos Imunológicos / Neoplasias Hepáticas / Neoplasias Pulmonares Tipo de estudo: Observational_studies / Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ósseas / Carcinoma Pulmonar de Células não Pequenas / Anticorpos Monoclonais Humanizados / Antígeno B7-H1 / Antineoplásicos Imunológicos / Neoplasias Hepáticas / Neoplasias Pulmonares Tipo de estudo: Observational_studies / Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article